Company
OncoC4 Inc.
We develop first-in-class and best-in-class medicines for hard-to-treat cancer and Alzheimer’s disease
Also known as OncoC4
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Rockville, MD, United States
- Founded
- 2020
- Legal name
- OncoC4, Inc
- oncoc4.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Leveraging innate and adaptive immune checkpoints—CTLA-4, PD-1/VEGF, CD24, and Siglec—we have the potential to target cancer cells and boost immune response like never before.
Funding snapshot
- Latest round
- Series B2025-10-02
Funding rounds
- Series B
- 2025-10-02
- Round, 2020
- 2020-12-221 investor
Loading relationship preview